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the behavioral, cellular and 
immune mediators of HIV-1 
acquisition: new insights from 
population genetics
timothy R. powell  1,2,4*, Rodrigo R. R. Duarte1,2,4, Matthew Hotopf3, Stephani L. Hatch3, 
Miguel de Mulder Rougvie2, Gerome D. Breen  1, cathryn M. Lewis  1 & Douglas f. nixon  2*
Millions are exposed to the human immunodeficiency virus type 1 (HIV-1) every year, but not all acquire 
the virus, suggesting a potential role for host genetics in the moderation of HIV-1 acquisition. Here, we 
analyzed summary statistics from the largest genome-wide association study of HIV-1 acquisition to-
date, consisting of 6,334 infected patients and 7,247 population controls, to advance our understanding 
of the genetic mechanisms implicated in this trait. We found that HIV-1 acquisition is polygenic and 
heritable, with SNP heritability estimates explaining 28–42% of the variance in this trait at a population 
level. Genetic correlations alongside UK Biobank data revealed associations with smoking, prospective 
memory and socioeconomic traits. Gene-level enrichment analysis identified EF-hand calcium binding 
domain 14 as a novel susceptibility gene for HIV–1 acquisition. We also observed that susceptibility 
variants for HIV-1 acquisition were significantly enriched for genes expressed in T-cells, but also in 
striatal and hippocampal neurons. Finally, we tested how polygenic risk scores for HIV-1 acquisition 
influence blood levels of 35 inflammatory markers in 406 HIV-1-negative individuals. We found that 
higher genetic risk for HIV-1 acquisition was associated with lower levels of C-C motif chemokine ligand 
17. Our findings corroborate a complex model for HIV-1 acquisition, whereby susceptibility is partly 
heritable and moderated by specific behavioral, cellular and immunological parameters.
Around 38 million people currently live with the human immunodeficiency virus type 1 (HIV-1) worldwide1, 
and millions more are exposed to potential infection every year through sexual contact, vertical transmission, 
or via the parenteral route2,3. First-line prevention strategies against acquisition comprise of the use of condoms 
and pre-exposure prophylaxis (PrEP), or abstinence from drugs or sex4. However, epidemiological studies have 
identified varying degrees of susceptibility to HIV-1, suggesting that host genetics may play a role in moderating 
acquisition, which could be explored in the context of preventive strategies. For example, studies conducted prior 
to the development of antiretroviral therapy observed that less than a third of babies born from HIV-1-positive 
mothers acquire HIV-15 and, similarly, that a proportion of highly exposed individuals are resistant to infection6. 
Supporting this hypothesis, homozygosity of the Δ32 mutation of the C-C chemokine receptor type 5 (CCR5) 
gene has been shown to protect against HIV-1 infection7–9, as the encoded protein is a co-receptor needed for 
viral entry. However, it remains unknown whether common genetic risk factors are also involved in host suscep-
tibility to acquisition.
HIV-1 acquisition is a complex phenotype that consists of behavioral risk parameters and biological fac-
tors moderating viral entry and replication. A better understanding of both behavioral and biological factors 
influencing acquisition has the potential to improve our basic comprehension of acquisition, inform preven-
tion strategies and clinical trials, and reduce social stigma. In this context, genome-wide association studies 
(GWAS) provide a powerful means to identify variants and risk mechanisms implicated in HIV-1 acquisition. 
No genome-wide significant polymorphisms have been robustly associated with HIV-1 acquisition to-date10–16. 
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However, population genetic methods have developed substantially in recent years, now allowing for powerful, 
biologically-informative analyses even in moderately-sized GWAS. For example, gene enrichment analyses can 
be applied to summary statistics to identify genes involved in risk, as well as cell types more likely mediating sus-
ceptibility. This is achieved by averaging association signals from multiple neighboring polymorphisms within 
protein-coding genes, and comparing lists of the resulting genes to the transcriptional profiles of mammalian cell 
types17,18. Methods like Linkage Disequilibrium Score Regression (LDSC)19 and Linkage Disequilibrium Adjusted 
Kinships (LDAK)20 further allow the estimation of SNP heritability based on GWAS results. Polygenic risk scores 
(PRS), in turn, can be used to explore genetic overlap between traits, and are useful in establishing the effect 
genetic predisposition has on biological parameters. PRS could even be used to model genetic risk for a trait 
(e.g. HIV-1 acquisition susceptibility) in a cohort of unaffected individuals (e.g. HIV-1-negative individuals). 
This, for example, could allow us to model the impact of genetic predisposition to HIV-1 acquisition on biolog-
ical systems prior to HIV-1 infection, which could ultimately aid in the identification of new vaccine or drug 
development strategies. Here, we apply these modern population genetic methods to the largest GWAS of HIV-1 
acquisition, and identify novel factors and complex traits associated with HIV-1 acquisition.
Results
HIV-1 acquisition is heritable and correlates with behavioral and socioeconomic traits. The 
largest GWAS meta-analysis of HIV-1 acquisition to-date tested over 8 million common polymorphisms for asso-
ciation with HIV-1 acquisition in 6,334 infected patients and 7,247 population controls10. We estimated the SNP 
heritability (SNP h2) of HIV-1 acquisition by analyzing these GWAS results using LD Hub (LDSC-based)19 and 
SumHer-GC20 (based on the LDAK model, correcting for possible hidden population structure). We observed 
that SNP h2 = 0.28 ± 0.05 (standard deviation; SD) under the LDSC model, suggesting that HIV-1 acquisition is 
a heritable trait, replicating a previous analysis of the same dataset21. Analysis with SumHer-GC showed a higher 
estimate of SNP h2 (0.42 ± 0.08), consistent with LDAK being able to capture a larger proportion of SNPs contrib-
uting to SNP h2, relative to LDSC.
To better understand which behavioral parameters might be important in moderating HIV-1 acquisition, we 
performed genetic correlation analyses leveraging on GWAS data from 516 heritable traits assessed in the UK 
Biobank via LD Hub, which contains genetic association results from up to 488,377 individuals. This LDSC-based 
analysis revealed 9 positive correlations with HIV-1 acquisition, including prospective memory, ascertained using 
cognitive tests (rg = 0.39, SE = 0.09, P = 7.15 × 10−6); lower levels of education, ascertained by having no higher 
qualifications (rg = 0.21, SE = 0.05, P = 5.59 × 10−5); self-reported smoking (rg = 0.28, SE = 0.06, P = 1.33 × 10−5); 
and self-reported vigorous exercising (rg = 0.27, SE = 0.06, P = 2.76 × 10−5; Bonferroni adjusted P (for 516 traits) 
<0.05 for all; Fig. 1A; Supplemental Table 1). We also observed 5 negative associations with acquisition, includ-
ing socioeconomic traits like alcohol intake with meals (rg = −0.28, SE = 0.06, P = 3.12 × 10−7), having a higher 
qualification (rg = −0.20, SE = 0.05, P = 1.99 × 10−5), and age at which female participants had their first live 
birth (rg = −0.25, SE = 0.06, P = 6.46 × 10−5). We validated the Bonferroni-significant genetic correlations using 
SumHer-GC (Fig. 1B), and observed highly concordant estimates of genetic correlation calculated between the 
two methods (Pearson’s r = 0.98, P = 2.59 × 10−9).
EFCAB14 as a novel susceptibility gene for HIV-1 acquisition. To perform our gene-level enrich-
ment analysis, gene-level statistics and weighted p-values were generated from GWAS summary statistics using 
MAGMA22, adjusting associations for gene size, single nucleotide polymorphism (SNP) density and linkage dis-
equilibrium. This analysis revealed a contribution of several protein-coding genes to HIV-1 acquisition, with 
gene-level Q-Q plots highlighting the degree of polygenicity observed, and the abundance of contributing genes 
relative to an expected normal distribution (Fig. 2A; Supplemental Table 2). We identified a novel gene involved 
in HIV-1 acquisition, the EF-hand calcium binding domain 14 (EFCAB14), on chromosome 1p33 (Z-score = 4.56, 
enrichment P = 2.56 × 10−6, Bonferroni corrected P = 4.7 × 10−2), which is expressed ubiquitously across tissues, 
according to The Genotype-Tissue Expression (GTEx) project23. The highest association signal at this locus is the 
non-coding variant rs8851 (P = 5.57 × 10−7; Fig. 2B), which is also an expression quantitative trait loci (eQTL) 
for EFCAB14. The risk (G-) allele of rs8851 is associated with lower expression of EFCAB14 in multiple tissues, 
including whole blood, skin, adipose tissue, the cerebellum and arteries (P < 1 × 10−3 for all)23. These findings 
suggest that genetic risk for HIV-1 acquisition at this locus is conferred via reduced expression of EFCAB14, 
and not by altered expression of neighboring genes such as the ATP synthase mitochondrial F1 complex assem-
bly factor 1 (ATPAF1) or the testis expressed 38 (TEX38) genes (Fig. 2C). Outside of chromosome 1p33, the 
top gene-level association signal was on chromosome 15q22.31, at the ubiquitin specific peptidase 3 gene (USP3), 
although this was not significant after multiple testing correction (enrichment P = 4.96 × 10−6, Bonferroni cor-
rected P > 0.05; Fig. 2D).
HIV-1 acquisition susceptibility variants are enriched within genes expressed in T-cells and 
striatal neurons. We aimed to investigate the cellular basis for the biological and behavioral parameters 
implicated in HIV-1 acquisition, and therefore investigated the cell types enriched for variants associated with 
this trait. Two independent gene-set enrichment analyses using FUMA24 showed that cells likely mediating acqui-
sition included T-cells (P = 8.54 × 10−4) and, independently, neurons from the striatum, hippocampus and globus 
pallidus under a false discovery rate of 10% (top association signals, respectively: P = 1.22 × 10−4, 2.49 × 10−4, and 
6.23 × 10−4; q < 0.10 for all; Fig. 3A,B, Supplemental Tables 3 and 4).
Polygenic risk score for HIV-1 acquisition is negatively associated with circulating CCL17 
levels. We utilized findings from the GWAS performed by McLaren and colleagues (2013) to calculate 
PRS for HIV-1 acquisition in an unrelated cohort of HIV-1-negative individuals, to measure how acquisition 
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predisposition correlated with levels of 35 blood-based inflammatory markers. Our rationale was to better under-
stand how genetic susceptibility expresses itself in the pre-exposed immune system, and in particular how it 
affects inflammatory cytokines, which are molecules that can be modified via pharmacological intervention, 
and are thought to be key moderators of HIV-1 infection25,26. A preliminary analysis utilized all polymorphisms 
associated with HIV-1 acquisition under a P association threshold (PT) = 0.5 to calculate the PRS, and to test its 
correlation with the levels of 35 inflammatory markers. This analysis showed that HIV-1 acquisition was sig-
nificantly and specifically associated with lower levels of the chemokine CCL17 (ß = −1644.32, standard error 
(SE) = 496.62, P = 1.00 × 10−3, Bonferroni corrected P (for 35 tests) = 3.50 × 10−2, variance explained = 2.74%; 
Fig. 3C). A sensitivity analysis revealed that PRS at every tested PT also significantly predicted levels of this 
chemokine, with highest significance at PT = 0.061 (ß = −800.52, SE = 180.07, P = 1.14 × 10−5, corrected 
P = 5.11 × 10−4, variance explained = 4.84%; Fig. 3D). Importantly, this effect was additionally observed when 
considering individuals of European-only ancestry in the cohort (ß = −794.27, SE = 190.81 P = 4.21 × 10−5), 
matching the ethnicity of the individuals in the base GWAS used to construct the PRS, and after removing the 
major histocompatibility complex from the PRS calculation (ß = −526.42, SE = 158.08, P = 9.50 × 10−4). The 
inverse correlation observed suggests that individuals that have a higher genetic predisposition to HIV-1 acquisi-
tion are more likely to have lower blood levels of CCL17 (Fig. 3E).
Figure 1. Genetic correlations between HIV-1 acquisition susceptibility and traits tested within the UK 
Biobank. (A) Correlations performed within LD Hub using the LDSC model to determine genetic correlations 
between HIV-1 acquisition and 516 heritable traits. The Bonferroni-significant correlations (rg) are displayed 
in red and delimited by the horizontal line (P = 0.05/516 traits = 8.38 × 10−5). (B) Validation of the Bonferroni-
significant findings using SumHer-GC, which is based on the LDAK model, adjusting for genomic control. 
The correlation values observed for the 14 Bonferroni-significant traits associated with HIV-1 acquisition 
in the LDSC method were highly concordant with results using the LDAK method (Pearson’s r = 0.98, 
P = 2.59 × 10−9).
4Scientific RepoRtS |         (2020) 10:3304  | https://doi.org/10.1038/s41598-020-59256-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
Discussion
HIV-1 acquisition consists of behavioral risk parameters moderating exposure as well as biological factors con-
trolling viral entry and replication. However, the genetic aspects of HIV-1 acquisition (outside of the CCR5 Δ32 
mutation) have been understudied, in part because no robust genome-wide significant variants were found 
in early studies10–16, which led to the premature assumption that acquisition was not substantially moderated 
by common genetic variants. The GWAS analyzed here, by McLaren and colleagues (2013), did not identify 
genome-wide significant polymorphisms associated with HIV-1 acquisition (after correcting association signals 
for frailty bias), but population genetic methods have advanced considerably in recent years, now allowing for 
powerful inferences about genetic traits using GWAS summary statistics19,22,24,27, even in moderately powered 
studies. For instance, we calculated heritability estimates of HIV-1 acquisition using cutting edge methods like 
LDSC and LDAK, which would otherwise be challenging using traditional twin and family methods. The level 
of SNP h2 observed for acquisition (LDSC: 0.28 ± 0.05; LDAK: 0.42 ± 0.08) was greater or comparable to that 
of traits considered highly heritable, such as body mass index (LDSC: 0.09 ± 0.01; LDAK: 0.33 ± 0.03), height 
(LDSC: 0.20 ± 0.02; LDAK: 0.46 ± 0.04), and schizophrenia (LDSC: 0.19 ± 0.01; LDAK: 0.42 ± 0.02)20. Overall, 
these results highlight the contribution of common variants to HIV-1 acquisition risk, showing this is a heritable 
trait.
To understand the underlying genetic factors associated with HIV-1 acquisition, we performed genetic correla-
tion analyses in LD Hub, which leverages on data from ~500,000 individuals from the UK Biobank, to investigate 
how acquisition genetics correlates with heritable traits assessed in this large population sample. We observed 
Figure 2. Gene-level enrichment analysis of the HIV-1 acquisition GWAS summary statistics identified a 
Bonferroni-significant susceptibility gene. (A) The quantile-quantile (Q-Q) plot shows the high number of 
observed genes associated with HIV-1 acquisition, compared to the number of expected genes assuming a 
normal distribution (dotted red line). Generated using FUMA17. (B) Gene-level Manhattan plot showing the 
novel susceptibility gene for HIV-1 acquisition on chromosome 1p33, EFCAB14. Generated using FUMA17. (C) 
Regional association plot demonstrating high linkage disequilibrium at the EFCAB14 locus. Generated using 
LDassoc51. (D) Regional association plot at the second highest association signal with HIV-1 acquisition outside 
of chromosome 1. Generated using LDassoc51.
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genetic correlations between HIV-1 acquisition and heritable phenotypes associated with socio-economic fac-
tors, corroborating previous epidemiological work, and further highlighting the need for prevention strategies 
tailored to individuals who most need it28. We further validated the genetic correlations using the independent 
SumHer-GC method, supporting these results.
Our results also validate and expand the current understanding of the biological basis of HIV-1 acquisition. 
In a preliminary enrichment analysis that aimed to identify the cell types that mediate HIV-1 acquisition sus-
ceptibility throughout the body, we observed that polymorphisms implicated in acquisition were enriched for 
genes expressed in T-cells, which are the main targets for HIV-1 replication29. We further tested the enrichment 
of HIV-1 variants for genes expressed across a range of neural cell types, since these cells mediate behavior and 
could explain certain genetic correlations observed with HIV-1 acquisition. We observed a significant enrich-
ment for striatal and hippocampal neurons in association with HIV-1 acquisition, which is particularly striking 
considering they are brain areas implicated in the regulation of reward and pleasure30,31. Alternatively, these cell 
types may represent those which harbor HIV-1 and most effectively hide it from the immune system, propagating 
a sustained infection. Furthermore, the gene-level enrichment analysis identified EFCAB14 as a susceptibility 
gene for HIV-1 acquisition, on chromosome 1p33. This gene is ubiquitously expressed in the body, and the risk 
Figure 3. HIV-1 acquisition genetics significantly overlaps with the expression profile of T-cells and neurons, 
and correlates with blood levels of CCL17. (A) Top 20 enrichment signals observed for murine non-neuronal 
cell types. (B) Top 20 enrichment signals observed for murine neuronal cell types. Green indicates significance 
under a false discovery rate of 10%. (C) Plot showing -log(p) of the association between 35 markers and 
a polygenic risk score for HIV-1 acquisition. The dashed line indicates Bonferroni significance. (D) Sensitivity 
analysis revealed that PRS at every PT significantly correlated with CCL17 levels in blood, with the highest 
significance at PT = 0.061. (E) Correlation between PRS for HIV-1 acquisition (PT = 0.061) adjusted for seven 
population dimensions, and CCL17 levels adjusted for age, gender, BMI, ethnicity, and smoking status.
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allele of rs8851 is known to reduce expression of EFCAB14 across multiple tissues. Proteins containing EF-Hand 
Calcium Binding domains in general are implicated in functions ranging from intracellular calcium buffering, 
signal transduction and muscle contraction32, but future studies are warranted to investigate the function of 
EFCAB14 specifically, particularly in the context of HIV-1 acquisition.
Another emerging method in population genetics is polygenic risk scoring33,34. We modelled how genetic 
risk for HIV-1 acquisition expresses itself in the pre-exposed immune profile using a cohort of HIV-1 negative 
individuals. By considering genetic risk as a continuous trait in a population setting, we can more powerfully 
determine the influences of the genetic risk signal on innate biological systems such as inflammatory marker 
expression, without confounders (e.g. drug use, other infections) more commonly associated with individu-
als from high-risk groups. Moreover, previous studies that have compared high-risk individuals who do not 
acquire HIV-1, with those that do, are likely confounded by the fact that HIV-1 has an influence on the immune 
system and inflammatory profile of the individual, which may not correspond to the pre-exposed immune profile 
associated with risk or resilience. In particular, we studied how genetic predisposition to HIV-1 acquisition affects 
inflammatory cytokines, which are immune messengers that are relatively easy to assay, can be modified via phar-
macological intervention, and are thought to be key moderators of HIV-1 infection25,26. We observed that PRS for 
HIV-1 acquisition inversely correlated with CCL17 levels in the blood of HIV-1 negative individuals, suggesting 
that levels of this chemokine should be considered in clinical trials for biomarker, drug and vaccine development. 
CCL17 is known to regulate the development and maturation of T-cells in the thymus, as well as their trafficking 
during inflammation35–37. Neutralization of this chemokine by antibody treatment has been shown to block the 
recruitment of T-cells in the lung (ameliorating respiratory allergy)38. We hypothesize that increased CCL17 
levels may increase the influx of inflammatory cells, which could help eliminate HIV-1-infected cells before the 
establishment of a systemic infection. However, CCL17 levels may represent only one of many biological mech-
anisms implicated in, or co-occurring with, HIV-1 acquisition susceptibility, and further research is needed to 
better understand this relationship.
Despite the insights provided, our study has limitations, including the modest cohort size of European-only 
individuals in the GWAS analyzed. Analyses of larger cohorts from different ancestry groups and 
well-characterized infection routes have the potential to improve our understanding of HIV-1 acquisition, by 
improving the identification of specific SNPs and genes involved. Future well-powered GWAS of HIV-1 acqui-
sition comparing high risk individuals who are infected versus those who are not will more likely tease apart the 
biological risk mechanisms implicated in viral resilience from the behavioral risk factors. This could be studied 
in areas where the risk for HIV-1 is already relatively high in the general population (e.g. South Africa), and 
where viral entry and replication may represent more important components of acquisition than risk behav-
iors. Furthermore, although we validated our estimates of heritability and genetic correlations by using two inde-
pendent methods, additional cohorts are needed to replicate our findings, including those obtained with the 
PRS analysis. Moreover, our genetic correlation analysis relies on self-report information from the UK Biobank, 
where individuals (aged 40+) are probably older than the average age of individuals diagnosed with HIV-1. 
Consequently, behaviors relevant to HIV-1 acquisition that may be more common in a younger cohort (e.g. drug 
use), could have been absent (or not reported) in the UK Biobank. Where we do find genetic correlations with 
HIV-1 risk, we cannot currently infer cause and effect, but this is something which may be achievable in the future 
via a Mendelian randomization design, once larger GWAS are able to detect robust genome-wide significant pre-
dictors of HIV-1 acquisition. Finally, the cytokine panel we investigated in association with PRS for acquisition 
was limited to 35 proteins, and it is possible that other inflammatory markers which we did not assess may be 
more relevant to this trait.
To conclude, our results show that HIV-1 acquisition genetics impinges upon behavioral, cellular, and immune 
factors. By leveraging on modern population genetic methods, our work provides a novel framework to study 
HIV-1 acquisition as a complex phenotype, advancing our understanding of the underlying risk factors. Our 
results suggest that in addition to environmental risk factors, there is a polygenic component to HIV-1 acquisition 
that should be explored further in clinical studies. In addition, our work supports the investigation of future inter-
vention strategies surrounding education and smoking behavior. In particular, there needs to be studies inves-
tigating whether smoking simply represents a proxy for unhealthy behaviors, or whether it actively influences 
biological processes linked to HIV-1 acquisition. Similarly, CCL17 and EFCAB14 should also be investigated with 
respect to their potential role as biomarkers for HIV-1 acquisition and as drug targets. As demonstrated here, 
GWAS can be very informative even when analyzing moderately sized cohorts, but its true potential to unveil the 
host genetic mechanisms influencing HIV-1 acquisition will likely only be unlocked with the creation of collabo-
rative initiatives and analyses of larger cohorts.
Material and Methods
GWAS summary statistics. We obtained summary statistics from the largest HIV-1 acquisition GWAS 
meta-analysis to-date, performed by McLaren and colleagues, which analyzed 6,334 HIV-1-positive individu-
als and 7,247 HIV-1-negative population controls of European ancestry, collected in Europe, North America, 
Australia and Africa10. The HIV-1-positive group consisted of individuals who acquired HIV-1 by sexual con-
tact (homosexual and heterosexual, N  =  3,311), via the parenteral route (injection drug use and transfusion, 
N =  1,046), or by unknown means (N = 2,086). The authors of this GWAS found no association of genotype with 
specific means of acquisition. We excluded variants not genotyped across all studies in the meta-analysis, those 
with a minor allele frequency <0.01, and those located within the major histocompatibility complex (chromo-
some 6, 26–34 Mb), due to its complex linkage disequilibrium structure.
Heritability estimates and genetic correlations. We applied LD score regression in LD Hub v1.9.119 to 
estimate the heritability of HIV-1 acquisition and to identify genetically associated traits, based on 516 heritable 
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phenotypes assessed in the UK Biobank39. The UK Biobank phenotypically characterized and genotyped 488,377 
participants aged between 40–69 years, enabling LD Hub to test for genetic correlations between HIV-1 acquis-
tion and traits of interest (e.g. disease states, behaviors and socioeconomic traits)40. Results were plotted in R41 
using the “EnhancedVolcano” library42. Estimation of SNP h2 and genetic correlations were also performed using 
SumHer-GC, from the LDAK package20, with the genomic control feature enabled, to control for potential hid-
den population structure in the data, even though the authors of the original GWAS did not identify genomic 
inflation (see McLaren and colleagues (2013)10). In the LDSC model, all SNPs are assumed to contribute equally 
to the phenotype, whereas in the LDAK model (which is expected to capture a larger proportion of heritability), 
a SNP with higher frequency is expected to contribute more towards heritability than one with lower frequency 
in the population, and a SNP in a region of low linkage disequilibrium contributes more than one in a region of 
high linkage disequilibrium.
Gene-level and gene set enrichment analyses. We used the Functional Mapping and Annotation of 
Genome-Wide Association Studies (FUMA) to identify genes and cell types associated with HIV-1 acquisition 
genetics, as described elsewhere17,18. Briefly, gene-level statistics and weighted p-values were generated from 
GWAS summary statistics, adjusting gene-level associations for gene size, SNP density and LD. Input SNPs were 
mapped to 18,439 protein coding genes using a 10 kb upstream and downstream window, and a Bonferroni cut-off 
was applied to determine significance (P cut-off = 0.05/18,439 protein-coding genes = 2.71 × 10−6)19. Next, the 
gene-set enrichment analysis used two single-cell RNA-sequencing datasets available in FUMA to identify cell 
types enriched for genes associated with HIV-1 acquisition under the false discovery rate of 10% (q < 0.10). 
Specifically, to identify particular tissues or organs involved in HIV-1 acquisition, we tested the transcriptional 
profile of 75 murine cell types (TabulaMuris_droplet_all) for enrichment with HIV-1 acquisition susceptibility 
genes. This dataset is a comprehensive collection of well-curated single cell transcriptome data from Mus mus-
culus, containing information from 100,605 cells from 20 organs and tissues43. To identify specific neural popu-
lations that could drive the behaviors observed in the genetic correlations, we tested the transcriptional profile 
of 565 neuronal cell types (DropViz_all_level2) for enrichment with HIV-1 acquisition susceptibility genes. This 
dataset contains the transcriptional signature of 690,000 cells from the mouse brain, which have been previously 
used to investigate the cellular mechanisms of behavior44.
the South east London community Health Study. We aimed to assess how HIV-1 acquisition risk 
might be moderated by an individual’s immune profile prior to infection, and so we tested how polygenic risk for 
HIV-1 acquisition correlated with the expression of 35 inflammatory markers. We studied HIV-1-negative pop-
ulation controls from the South East London Community Health Study (SELCoH)45–47, where HIV-1-negative 
status was determined based on self-report. For further details on the full SELCoH study, please see Hatch et al.43. 
SELCoH aimed to investigate mental and physical health in the general population in London, UK. The sub-
sample analyzed in our study consisted of 406 individuals for which both inflammatory and genetic data were 
available. The SELCoH study received approval from King’s College London research ethics committee, reference 
PNM/12/13-152. Informed written consent was obtained from all participants at the time of sample collection. 
The 35 inflammatory markers represent adequately expressed cytokines from an initial panel of 42, which were 
originally assayed in relation to major depression risk, as described previously48. The mean age of our sample 
was 48.7 ± 15.1 (standard deviation), with a mean body mass index of 27.3 ± 5.5. The cohort is representative of 
the source population and consisted of 45.3% males; 20.9% current smokers and 40.4% ex-smokers; and 56.8% 
White British, 8.4% Black Caribbean, 10.9% Black African, 14.6% White Other, 6.2% Non-White Other, and 3.2% 
Mixed. Participants received detailed and repeated phenotypic assessments as part of three separate phases. The 
first phase aimed to assess common physical and mental disorders in South East London; the second, to examine 
the roles of historical social context and policy in shaping patterns of health inequalities; and the third, to collect 
biological specimens from a subset of participants, including blood for serum separation and DNA for genotyp-
ing. Serum and DNA were extracted and stored at −80 °C until use, as described previously47,48.
Quantification and analysis of cytokines. Serum levels (pg/mL) of 35 blood-based markers were 
assessed in blood samples from the SELCoH cohort using multiplex ELISA-based technology provided by the 
Meso Scale Discovery Biomarker kits, as described previously48. For each marker, we adjusted for the effects of 
assay run, age, gender, body mass index (BMI), smoking (never, current, former) and ethnicity, by taking stand-
ardized residuals (z-scores). Z-scores were then used in downstream PRS analyses.
DnA genotyping. DNA samples from the SELCoH cohort were sent to the Affymetrix Research Services 
Laboratory in Santa Clara, California, USA. Genotyping was assayed using the UK Biobank Axiom Array (r3) 
which comprises of 820,967 genetic markers (Affymetrix, California, United States). Genotype data was put 
through quality control measures as described previously, and used to construct polygenic risk scores47.
polygenic risk scores. Individualized polygenic risk scores (PRS) within the SELCoH sample were calcu-
lated using PRSice-2, a PRS quantification software33,34. This pipeline uses summary statistics from a base GWAS 
to generate individualized PRS in a target dataset. Briefly, the number of risk alleles in the base dataset are mul-
tiplied by SNPs’ effect sizes to generate individualized PRS in the target dataset. PRSice-2 clumps SNPs in the 
genotype files of the target dataset and removes those in high LD to avoid polygenic score inflation. For our initial 
screen, we constructed a PRS using all SNPs in the GWAS with P < 0.5. We tested whether this score predicted 
adjusted inflammatory marker levels in PRSice-2, covarying for seven population dimensions generated using 
principal component analysis applied to LD-pruned SNPs in PLINK 1.949. Our relaxed p-value threshold (PT) 
was initially selected based on earlier studies which revealed that highly polygenic phenotypes in moderately 
powered GWAS are better captured using a relaxed cut-off 50. We subsequently performed sensitivity analyses for 
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significant associations using a wide range of p-value thresholds, from p = 0.001 to p = 0.5, with 0.001 increments. 
This allowed us to determine the optimal PT that explained the most variance. Furthermore, as part of a sensitivity 
test, once an optimal polygenic predictor was established, we tested its ability to predict inflammatory markers: 
(i) once the MHC region was excluded, (ii) when applied to individuals of European-only ancestry. This was per-
formed to confirm that the result was not driven by confounding effects related to the complex structure of the 
MHC region, or to the genetic admixture in the SELCoH sample.
Data availability
Summary statistics were made available to us upon request to McLaren and colleagues10. Due to ethical 
restrictions, the SELCoH data is not publicly available. Details on the SELCoH sample and requests to access 
phenotype and inflammation data can be made at http://www.slam.nhs.uk/research/selcoh/selcoh-projects. 
Access to SELCoH genetic data requires local approval via the NIHR Bioresource (bioresource@kcl.ac.uk). 
Genetic correlations were performed using LD Hub and UK Biobank data, which are open access (http://ldsc.
broadinstitute.org/ldhub/).
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